KaloBios Pharmaceuticals (KBIO) Squeezes Toward $30/Share
KaloBios Pharmaceuticals (NASDAQ: KBIO) is pushing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
